
Sign up to save your podcasts
Or


In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
By American Academy of Neurology4.8
129129 ratings
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577

496 Listeners

300 Listeners

50 Listeners

290 Listeners

3,333 Listeners

263 Listeners

13 Listeners

22 Listeners

195 Listeners

515 Listeners

364 Listeners

6,411 Listeners

179 Listeners

369 Listeners

79 Listeners